Investment
Features
FeesSafety
Academy
More
Pluang+

Leatt's H1 revenue rises 14%, net income up 19%, driven by strong consumer sales and new product partnerships

Company Fundamentals
14 Aug 2026
PRNewsWire
View Source
Bullish
pluang ai news

Leatt Corporation reported a 14% increase in global revenues to $35.9 million and a 19% rise in net income to $2.68 million for the first six months of 2026, fueled by a 61% jump in consumer direct sales. Despite a modest 1% revenue growth in Q2 due to supply chain delays, the company resolved these issues and saw strong demand for body armor and helmets. Leatt also announced a partnership with Cardo Systems to integrate wireless communication technology into its MOTO 8.5 helmet, aiming to launch this innovative product later in 2026. The company plans to continue investing in global sales teams and product development to sustain growth.

More News

Rubrik director Yvonne Wassenaar sold 721 shares at $75 before stock rally began.

Rubrik director Yvonne Wassenaar sold 721 shares at $75 before stock rally began.

Yvonne Wassenaar, a director at Rubrik, sold 721 shares at a price of $75 each just before the company's stock experienced a significant rally. This sale occurred ahead of the stock's upward movement, which may be of interest to investors tracking in...

Market News
Bearish
52 minutes ago
Gold and silver prices rise as weaker U.S. retail sales boost hopes for Fed rate pause in September

Gold and silver prices rise as weaker U.S. retail sales boost hopes for Fed rate pause in September

Gold and silver prices increased in early U.S. trading following a surprise 0.6% drop in July retail sales, which strengthened market expectations that the Federal Reserve may hold interest rates steady in September. The softer consumer data, combine...

Market News
Neutral
4 hours ago
Clover Health posts strong Medicare Advantage growth, profit, and outlook, keeping a strong buy rating.

Clover Health posts strong Medicare Advantage growth, profit, and outlook, keeping a strong buy rating.

Clover Health (CLOV) reported significant growth with a 48% year-over-year increase in Medicare Advantage membership, 56% revenue growth, and 54% gross profit growth. This performance is driven by cohort maturation and the Clover Assistant platform. ...

Company Fundamentals
Bullish
4 hours ago
Celcuity remains a Buy as FDA approval and strong trial data boost confidence in its cancer drug launch.

Celcuity remains a Buy as FDA approval and strong trial data boost confidence in its cancer drug launch.

Celcuity Inc. is rated a Buy following the FDA approval of its cancer drug REVTORPYK/gedatolisib and its rapid inclusion in NCCN Category 1 guidelines, which reduce risks for clinical and commercial adoption. The company has made significant upfront ...

Market News
Bullish
4 hours ago
Tapestry shares drop 16.5% post-earnings despite beating Q4 estimates, raising questions on guidance.

Tapestry shares drop 16.5% post-earnings despite beating Q4 estimates, raising questions on guidance.

Tapestry, owner of Coach and Kate Spade, beat Q4 revenue and earnings expectations but saw its stock fall 16.5% due to cautious FY2027 guidance. Revenue rose 8.9% to $1.88 billion and EPS beat estimates at $1.32, with margin expansion. However, the g...

Company Fundamentals
Neutral
4 hours ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App